Page last updated: 2024-08-26

peptide elongation factor 2 and ddd107498

peptide elongation factor 2 has been researched along with ddd107498 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abraham, TS; Almeida, MJ; Angulo-Barturen, I; Avery, VM; Baragaña, B; Basak, R; Bebrevska, L; Blagborough, AM; Bolscher, JM; Brock, PM; Campbell, M; Campbell, S; Campo, B; Charman, SA; Churcher, TS; Dechering, KJ; Delves, MJ; Fairlamb, AH; Ferrer-Bazaga, S; Fidock, DA; Frearson, JA; Gamo, FJ; Gilbert, IH; Gray, DW; Grimaldi, R; Hallyburton, I; Jiménez-Díaz, MB; Kyle, DE; Lee, MC; Leroy, D; Luksch, T; Marfurt, J; Martínez, MS; Meister, S; Norcross, NR; Norval, S; Noviyanti, R; Osuna-Cabello, M; Otto, TD; Porzelle, A; Pradhan, A; Price, RN; Proto, WR; Rayner, JC; Read, KD; Riley, J; Ruecker, A; Sala, KA; Sanz, LM; Sauerwein, RW; Siegl, P; Simeons, F; Sinden, RE; Stojanovski, L; Thomas, J; Upton, LM; Willis, PA; Winzeler, EA; Wirjanata, G; Wittlin, S; Woodland, A; Wyatt, PG; Zakutansky, SE; Zuccotto, F1
Badolo, L; Dhingra, SK; Fidock, DA; Giddins, MJ; Greco, B; Gumpp, C; Jonat, B; Oeuvray, C; Rottmann, M; Spangenberg, T; Yin, X1

Other Studies

2 other study(ies) available for peptide elongation factor 2 and ddd107498

ArticleYear
A novel multiple-stage antimalarial agent that inhibits protein synthesis.
    Nature, 2015, 06-18, Volume: 522, Issue:7556

    Topics: Animals; Antimalarials; Drug Discovery; Female; Gene Expression Regulation; Life Cycle Stages; Liver; Malaria; Male; Models, Molecular; Peptide Elongation Factor 2; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Protein Biosynthesis; Quinolines

2015
Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
    Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4

    Topics: Animals; Antimalarials; Drug Resistance; Drug Therapy, Combination; Hemeproteins; Malaria, Falciparum; Mice; Mice, SCID; Naphthyridines; Peptide Elongation Factor 2; Plasmodium falciparum; Quinolines

2020